Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


CUMBERLAND PHARMACEUTICALS REPORTS 2.5M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2020


 

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, released its 2020 Sustainability Report, which details the company's activities pertaining to environmental, social and governance (ESG) matters.

"After issuing our inaugural ESG report last year, we remain committed to sustainability and to maintaining transparency of our corporate operations," said Cumberland Pharmaceuticals' ESG Board Director Caroline Young. "As the largest biopharmaceutical company founded and headquartered in the Mid-South, we hold ourselves to the highest standards of ethical practices and understand the importance of recognizing and addressing our impact on our constituents, the community and the environment."

The report states that in 2020 Cumberland provided nearly 2.5 million patient doses of its products, safely disposed of over 4,000 pounds of expired and damaged products and had no product recalls. The company also had no product listings on the FDA's MedWatch Safety Alerts for Human Medical Products, no products identified in the FDA Adverse Event Reporting System and no clinical trials terminated due to failure to practice good clinical standards.

"2020 was a challenging year and we are proud to have responded to the pandemic with a fast and coordinated approach to ensure the health and safety of our team. We were able to continue the delivery of our products, while addressing the interests of our shareholders, employees, partners and community," said A.J. Kazimi, chief executive officer of Cumberland Pharmaceuticals.

Cumberland is committed to delivering high-quality pharmaceutical products to improve patient care. The 2020 Sustainability Report notes that the company has implemented an initiative to serialize all commercial products sold in the United States, allowing it to track every unit distributed and prevent counterfeit drugs from entering the market under the Cumberland brand. The report also states that through its coupon program, Cumberland covers up to 90% of patient prescription costs for its gastrointestinal products.

Additionally, the report highlights the biopharmaceutical company's investment in its employees through its continuing education programs, employee development initiatives and employee awards. Cumberland's workforce is 46% women - and 18% of its employees are minorities.

For more information on how Cumberland is addressing topics of importance to its employees, investors and the communities it serves, please view Cumberland's 2020 Sustainability Report at www.cumberlandpharma.com on the Investor Relation section's Corporate Governance page.

 
Share:

Related Articles:


Recent Articles

Grant Creates Center for Maternal, Pediatric Precision Therapeutics

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health (NIH) to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics (MPRINT).

Read More

Change in Respiratory Care Strategies for Preterm Infants Improves Health Outcomes

A decade's worth of data shows that neonatologists are shifting the type of respiratory support they utilize for preterm infants, a move that could lead to improved health outcomes.

Read More

The Fear of the Unknown: Anxiety and the Upcoming School Year

Nurture the Next Discusses Ways to Help Children Cope as they Return to School

Read More

Older Age, Chronic Co-Morbidities Associated with More Severe COVID Disease in Children

Over the course of the pandemic, researchers nationwide noticed differences in COVID-19 disease between children and adults.

Read More

Envision Healthcare Shares Resources to Support Clinician Mental Health

National Medical Group Uses Systematic Professional Well-Being Approach to Support Clinicians' Wellness

Read More

Monroe Carell Jr. Children's Hospital at Vanderbilt Debuts New State-of-the-Art Maternal Fetal Clinic

Expectant parents never imagine they'll face tough decisions about treatments or surgeries for their unborn babies following a potentially devastating fetal diagnosis. But for thousands of families each year, this is a harsh reality.

Read More

Answering the Call to Train More Physicians

Local healthcare leaders address the growing need for doctors nationwide

Read More

Back to School with COVID

After enjoying a taste of 'return to normal' earlier this year, the Delta variant has changed the trajectory of the pandemic and plunged communities into crisis again.

Read More

Addressing Kids' Health in Tennessee

New plans designed to impact social determinants of health among Tennessee's kids

Read More

ACS Updates Children's Surgery Verification Program Standards

Updated standards from ACS Children's Surgery Verification Program emphasize new patient care expectations for participating hospitals.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: